Change of telomere length in angiotensin II-induced human glomerular mesangial cell senescence and the protective role of losartan

Molecular Medicine Reports

Volumn 4, Issue 2, 2011, Pages 255-260

  Feng, Xin ^a,b   Wang, Lining ^a   Li, Yao ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin II; Losartan; Senescence; Telomere length

Indexed keywords

ANGIOTENSIN II; BETA GALACTOSIDASE; LOSARTAN; PROTEIN P21; PROTEIN P53;

ARTICLE; CELL AGING; CELL CYCLE; CELL CYCLE ARREST; CELL STRUCTURE; CHROMOSOME SIZE; CONTROLLED STUDY; CYTOMETRY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KIDNEY CELL CULTURE; MESANGIUM CELL; PROTEIN EXPRESSION; SOUTHERN BLOTTING; TELOMERE; WESTERN BLOTTING;

ANGIOTENSIN II; BETA-GALACTOSIDASE; BLOTTING, WESTERN; CELL AGING; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FLOW CYTOMETRY; HUMANS; LOSARTAN; MESANGIAL CELLS; PROTECTIVE AGENTS; TELOMERE; TUMOR SUPPRESSOR PROTEIN P53;

EUKARYOTA;

EID: 79551697149     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.436     Document Type: Article

References (24)

1. Roland Sehmitt and Lloyd G Cantley: The impact of aging on kidney repair. Am J Physiol Renal Physiol 294: 1265-1272, 2008.
2. Famulski KS and Halloran PF: Molecular events in kidney aging. Curr Opin Nephrol Hypertens 14: 243-248, 2005.
3. Kiberd BA and Clase CM: Cumulative risk for developing end-stage renal disease in the US population. Am J Soc Nephrol 13: 1635-1644, 2002. (Pubitemid 34579252)
4. Zhou XJ, Saxena R Liu Z, Vaziri ND and Silva FG: Renal senescence in 2008: progress and challenges. Int Urol Nephrol 40: 823-839, 2008.
5. Jiang H, Ju Z and Rudolph KL: Telomere shortening and ageing. Z Gerontol Geriat 40: 314-324, 2007
6. Blackburn EH: Switching and signaling at the telomere. Cell 106: 661-673, 2001.
7. Garbe J, Wong M and Wigington D: Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells. Oncogene 18: 2169-2180, 1999. (Pubitemid 29186918)
8. Weidmann P, De Myttenaere-Bursztein S and Maxwell MH: Effect of aging on plasma renin and aldosterone in normal man. Kidney Int 8: 325-333, 1975.
9. Imanishi T, Kobayashi K, Kuroi A, Ikejima H and Akasaka T: Pioglitazone inhibits angiotensin II-induced senescence of endothelial progenitor cells. Hypertens Res 31: 757-765, 2008. (Pubitemid 351772867)
10. Long DA, Price KL and Herrera-Acosta J: How does angiotensin II cause renal injury. Hypertension 43: 722-723, 2004. (Pubitemid 38405576)
11. Min LJ, Mogi M, Iwai M and Horiuchi M: Signaling mechanisms of angiotensin II in regulating vascular senescence. Ageing Res Rev 8: 113-121, 2009.
12. Percy C, Pat B, Poronnik P and Gobe G: Role of oxidative stress in age-associated chronic kidney pathologies. Adv Chron Kidney Dis 12: 78-83, 2005. (Pubitemid 40255607)
13. Harman D: The free radical theory of aging. Antioxid Redox Signal 5: 557-561, 2003.
14. Blackburn EH and Gall JG: A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol 120: 33-53, 1978. (Pubitemid 8312910)
15. Halvorsen TL, Leibowitz G and Levine F: Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol Cell Biol 19: 1864-1870, 1999.
16. Levy D, Neuhausen SL and Hunt SC: Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology. Proc Natl Acad Sci USA 107: 9293-9298, 2010.
17. Melk A, Ramassar V and Helms LM: Telomere shortening in kidneys with age. J Am Soc Nephrol 11: 444-453, 2000.
18. Jung T, Bader N and Grune T: Lipofuscin: formation distribution and metabolic consequences. Ann NY Acad Sci 1119: 97-111, 2007. (Pubitemid 350191226)
19. Mendoz-Nunez VM, Ruiz-Ramos M and Sanchez-Rodriguez MA: Aging related oxidative stress in healthy humans. Tohoku J Exp Med 213: 261-268, 2007. (Pubitemid 350238025)
20. Janakiraman K, Chad T and Matthew R: Ink4a/Arf expression biomarker of aging. J Clin Invest 114: 1299-1307, 2004.
21. Kusumoto M, Ogawa T, Mizumoto K, Ueno H, Niiyama H, Sato N, Nakamura M and Tanaka M: Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells. Clin Cancer Res 5: 2140-2147, 1999. (Pubitemid 29399270)
22. De Cavanagh EM, Inserra F, Ferder L and Fraga CG: Enalapril and captopril enhance glutathione dependent antioxidant defenses in mouse tissues. Am J Physiol Regul Integr Comp Physiol 278: R572-R577, 2000. (Pubitemid 30158114)
23. Michel JB, Heudes D, Michel O, Poitevin P, Philippe M, Scalbert E, Corman B and Levy BI: Effect of chronic ANG I-converting enzyme inhibition on aging processes. I. Kidney structure and function. Am J Physiol 266: R124-R135, 1994.
24. De Cavanagh EM, Piotrkowski B, Basso N, Stella I, Inserra F, Ferder L and Fraga CG: Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J 17: 1096-1098, 2003.